K. H. Morsy, A. Zaghloul, and M. Mahmoud, “Can eicosapentaenoic acid maintain the original ribavirin dose or affect the response during the treatment course of chronic hepatitis C virus (HCV) patients?”, Turkish Journal of Gastroenterology, vol. 27, no. 1, pp. 55–61, Jan. 2016.